139 related articles for article (PubMed ID: 19129997)
1. Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk.
Cáceres DD; Quiñones LA; Schroeder JC; Gil LD; Irarrázabal CE
Lung; 2009; 187(2):110-5. PubMed ID: 19129997
[TBL] [Abstract][Full Text] [Related]
2. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
[TBL] [Abstract][Full Text] [Related]
3. Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population.
Liu D; Wang F; Guo X; Wang Q; Wang W; Xu H; Xu G
Mol Biol Rep; 2013 Jan; 40(1):645-9. PubMed ID: 23054019
[TBL] [Abstract][Full Text] [Related]
4. Association of a p53 codon 72 gene polymorphism with environmental factors and risk of lung cancer: a case control study in Mizoram and Manipur, a high incidence region in North East India.
Saikia BJ; Das M; Sharma SK; Sekhon GS; Zomawia E; Singh YM; Mahanta J; Phukan RK
Asian Pac J Cancer Prev; 2014; 15(24):10653-8. PubMed ID: 25605155
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.
Kiyohara C; Horiuchi T; Miyake Y; Takayama K; Nakanishi Y
Oncol Rep; 2010 May; 23(5):1361-8. PubMed ID: 20372852
[TBL] [Abstract][Full Text] [Related]
6. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India.
Malakar M; Devi KR; Phukan RK; Kaur T; Deka M; Puia L; Sailo L; Lalhmangaihi T; Barua D; Rajguru SK; Mahanta J; Narain K
Asian Pac J Cancer Prev; 2014; 15(2):717-23. PubMed ID: 24568485
[TBL] [Abstract][Full Text] [Related]
8. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
[TBL] [Abstract][Full Text] [Related]
9. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
10. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
Qiao Q; Hu W
Lung; 2013 Aug; 191(4):369-77. PubMed ID: 23595658
[TBL] [Abstract][Full Text] [Related]
11. p16 gene silencing along with p53 single-nucleotide polymorphism and risk of esophageal cancer in Northeast India.
Das M; Sharma SK; Sekhon GS; Mahanta J; Phukan RK; Jalan BK
Tumour Biol; 2017 May; 39(5):1010428317698384. PubMed ID: 28459370
[TBL] [Abstract][Full Text] [Related]
12. Association of P53 codon 72 polymorphism and lung cancer in an ethnic Iranian population.
Eydian Z; Asna'ashari AM; Behravan J; Sharifi-Rad J; Entezari Heravi R
Cell Mol Biol (Noisy-le-grand); 2016 Aug; 62(9):34-8. PubMed ID: 27585259
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
14. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
15. hOGG1, p53 genes, and smoking interactions are associated with the development of lung cancer.
Cheng Z; Wang W; Song YN; Kang Y; Xia J
Asian Pac J Cancer Prev; 2012; 13(5):1803-8. PubMed ID: 22901126
[TBL] [Abstract][Full Text] [Related]
16. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS; Shin MH
Lung Cancer; 2011 Sep; 73(3):264-7. PubMed ID: 21316118
[TBL] [Abstract][Full Text] [Related]
17. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari A; Bahl C; Singh N; Behera D; Sharma S
Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
[TBL] [Abstract][Full Text] [Related]
18. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
19. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.
Gochhait S; Bukhari SI; Bairwa N; Vadhera S; Darvishi K; Raish M; Gupta P; Husain SA; Bamezai RN
Breast Cancer Res; 2007; 9(5):R71. PubMed ID: 17945002
[TBL] [Abstract][Full Text] [Related]
20. p53 codon 72 polymorphism as a progression index for bladder cancer.
Lin HY; Huang CH; Yu TJ; Wu WJ; Yang MC; Lung FW
Oncol Rep; 2012 Apr; 27(4):1193-9. PubMed ID: 22200788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
